China 
Africa 
Explore chapters and articles related to this topic
The Anxious Couple
Published in Len Sperry, Katherine Helm, Jon Carlson, The Disordered Couple, 2019
Katie L. Springfield, Rosa M. Macklin-Hinkle
Finally, a number of assessment measures are available to help assess for the presence and severity of OCD symptoms. The Yale–Brown Obsessive–Compulsive Scale (Y-BOCS) has a number of variations to suit different settings and evaluations styles. The Y-BOCS self-report measure comprises a symptom checklist and severity scale to rate both obsessions and compulsions (Rapp, Bergman, Piancentini, & McGuire, 2016). In addition to a self-report measure, a clinician-rated measure, the Dimensional Yale–Brown Obsessive–Compulsive Scale (DY-BOCS), is also available. Shorter OCD assessment tools include the Obsessive–Compulsive Inventory–Revised (OCI-R), the Florida Obsessive–Compulsive Inventory (FOCI), and the Dimensional Obsessive–Compulsive Scale (DOCS).
Nutritional Ergogenic Aids: Introduction, Definitions and Regulatory Issues
Published in Ira Wolinsky, Judy A. Driskell, Nutritional Ergogenic Aids, 2004
Ira Wolinsky, Judy A. Driskell
A double-blind placebo-controlled study indicated that persons suffering from obsessive-compulsive disorder (OCD) had significantly lower scores on the Yale-Brown Obsessive Compulsive Scale (YBOCS), a tool used by psychiatrists and researchers of human behavior to assess affective disorders such as OCD. These researchers conducted a crossover trial with 18 g/day of inositol or placebo for 6 weeks each, which means that both groups of OCD patients received the drug and the placebo, but at different blocks of time for 6 weeks each. Significant reductions in YBOCS scores were observed in subjects during those blocks of time in which they were being supplemented with inositol, demonstrating therapeutic benefits.22Attention Deficit Disorder with Hyperactivity
Antidepressants for the Treatment of Depression and Anxiety Disorders: Same Mechanism of Action?
Published in Siegfried Kasper, Johan A. den Boer, J. M. Ad Sitsen, Handbook of Depression and Anxiety, 2003
R. Hamish McAllister-Williams, Stephen P. Tyrer
The Epidemiological Catchment Area survey in the United States reported a lifetime prevalence of OCD of 2.5% [17]. Two-thirds of OCD patients have a lifetime history of major depression and one-third satisfy criteria for major depression at the time of first evaluation [18]. Conversely, over 20% of bipolar and 10% of unipolar affective disorder patients, respectively, have comorbid OCD [19]. Despite the high rates of co-occurrence of both depressive and obsessive-compulsive symptomatology in patients, it is possible to selectively investigate effects of treatment on core OCD symptoms using well-validated scales such as the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [20,21]. This is an important issue because it allows the possibility of examining the specific effects of anti-depressants in OCD.
Cybersex addiction in a gay man: a case report
Published in Journal of Addictive Diseases, 2021
Valentin Skryabin, Mikhail Zastrozhin, Egor Chumakov
To rate the severity of obsessive-compulsive symptoms, The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was used. A total score was 23, which corresponds to a moderate obsessive-compulsive disorder. Time occupied by obsessive thoughts regarding masturbation and sex was moderate (1–3 hrs/day). The patient stated that those obsessive thoughts interfered with his personal, social, or work life substantially causing a severe distress. M. tried to resist the obsessive thoughts, but he realized that he wasn’t able to control them. The patient spent more time in compulsive behavior and experienced severe anxiety if he was prevented from performing that. He showed an insight into his problem, but recognized only little control over that. Y-BOCS Symptom Checklist revealed the presence of contamination, sexual, and miscellaneous obsessions, as well as checking compulsions.
Beliefs of cancer patients in Saudi Arabia
Published in Journal of Psychosocial Oncology, 2020
Rolina Al-Wassia, Faten Al-Zaben, Mohammad Gamal Sehlo, Harold G. Koenig
Obsessions with contamination may underlie beliefs regarding the spread of cancer or its treatments, especially if such beliefs are resistant to education. The obsessions subscale of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was used to assess obsessions related to contamination by cancer.27 Participants were first asked if they had any concerns that they may either now or in the past have infected someone with their cancer; responses were rated on a 0 to 2 scale (0 = “no, never”; 1 = “yes, in past”; and 2 = “yes, current”). This was then followed by five questions asking about hours per day spent on thoughts regarding contamination, interference with daily life caused by such thoughts, distress experienced over these thoughts, resistance made against the thoughts, and efforts to exert control over them. Each question was rated on a 0 to 4 scale from “complete control” to “no control,” “incapacitating,” “near constant, disabling,” or “extreme.” The five items were summed to create an “obsessions with contamination scale” (OCS) ranging from 0 to 20; participants who reported “no” to the first question indicating they never had concerns about infecting someone with cancer were automatically assigned a 0 on this scale. The internal consistency of the 5-item scale was 0.90.
Randomized crossover feasibility trial of helminthic Trichuris suis ova versus placebo for repetitive behaviors in adult autism spectrum disorder
Published in The World Journal of Biological Psychiatry, 2020
Eric Hollander, Genoveva Uzunova, Bonnie P. Taylor, Rachel Noone, Emma Racine, Ellen Doernberg, Katherine Freeman, Casara Jean Ferretti
4. Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) is designed to measure the severity of obsessions and compulsions, independent from one another, without bias towards their content. Although initially validated for OCD (Kim et al. 1994), this scale has also been validated to measure the severity of repetitive and restricted behaviours in the ASD population (Anagnostou et al. 2011). It is a clinician-rated instrument that allows the clinician to incorporate all data available, including patient report, and clinician and caregiver observations. The scale consists of a Symptom Checklist, Target Symptom List to guide the clinician through the questions, followed by separate ratings scales for obsessions and compulsions. Internal consistency is high, with a Cronbach’s alpha of 0.89.